J.P. Issa
The Johns Hopkins Oncology Center
Baltimore
USA
Name/email consistency: high
- Methylation of the ABL1 promoter in chronic myelogenous leukemia: lack of prognostic significance. Issa, J.P., Kantarjian, H., Mohan, A., O'Brien, S., Cortes, J., Pierce, S., Talpaz, M. Blood (1999)